Xylem Inc. vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 71)

Xylem Inc.

LeaderManufacturing

Water Technology

Xylem Inc. (XYL) reported ~$8.3B revenue in FY2024. Global water technology company providing pumps, treatment systems, and smart water infrastructure for utilities and industrial users. HQ: Washington, DC.

AI VisibilityBeta
Overall Score
B71
Category Rank
#1 of 1
AI Consensus
56%
Trend
stable
Per Platform
ChatGPT
69
Perplexity
82
Gemini
82

About

Xylem Inc. is a global water technology company providing equipment and services for water and wastewater applications across utilities, industrial, commercial, and residential end markets. Spun off from ITT Corporation in 2011, Xylem designs and manufactures pumps, mixers, water quality testing equipment, analytics platforms, and advanced metering infrastructure (AMI) used to move, treat, measure, and manage water and wastewater. The company's 2023 acquisition of Evoqua Water Technologies for $7.5 billion significantly expanded its water treatment capabilities.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

71
Overall Score
90
#1
Category Rank
#83
56
AI Consensus
58
stable
Trend
stable
69
ChatGPT
84
82
Perplexity
97
82
Gemini
99
76
Claude
86
66
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.